146 related articles for article (PubMed ID: 9015433)
1. Somatostatin receptor imaging of olfactory neuroblastoma.
Ramsay HA; Kairemo KJ; Jekunen AP
J Laryngol Otol; 1996 Dec; 110(12):1161-3. PubMed ID: 9015433
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.
Rostomily RC; Elias M; Deng M; Elias P; Born DE; Muballe D; Silbergeld DL; Futran N; Weymuller EA; Mankoff DA; Eary J
Head Neck; 2006 Apr; 28(4):305-12. PubMed ID: 16470879
[TBL] [Abstract][Full Text] [Related]
3. Expression of somatostatin receptors in arginine vasopressin hormone-secreting olfactory neuroblastoma--report of two cases.
Freeman SR; Mitra S; Malik TH; Flanagan P; Selby P
Rhinology; 2005 Mar; 43(1):61-5. PubMed ID: 15844504
[TBL] [Abstract][Full Text] [Related]
4. [Olfactory esthesioneuroblastoma: scintigraphic expression of somatostatin receptors].
García Vicente A; García Del Castillo E; Soriano Castrejón A; Alonso Farto J
Rev Esp Med Nucl; 1999 Oct; 18(5):367-70. PubMed ID: 10562667
[TBL] [Abstract][Full Text] [Related]
5. Olfactory neuroblastoma: MR evaluation.
Li C; Yousem DM; Hayden RE; Doty RL
AJNR Am J Neuroradiol; 1993; 14(5):1167-71. PubMed ID: 8237698
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Olfactory Neuroblastoma in Remote Leptomeninges, Mimicking Intracranial Meningioma.
Kim YS; Jung S; Jang WY; Lee KH; Moon KS; Kim IY
World Neurosurg; 2016 Dec; 96():612.e9-612.e14. PubMed ID: 27609444
[TBL] [Abstract][Full Text] [Related]
7. [Magnetic resonance imaging of olfactory neuroblastoma].
Iio M; Homma A; Furuta Y; Fukuda S
Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):142-8. PubMed ID: 16615428
[TBL] [Abstract][Full Text] [Related]
8. Remote orbital recurrence of olfactory neuroblastoma (esthesioneuroblastoma).
Breazzano MP; Lewis JS; Chambless LB; Rohde SL; Sobel RK
Orbit; 2017 Aug; 36(4):247-250. PubMed ID: 28362545
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.
Lechner M; Takahashi Y; Turri-Zanoni M; Liu J; Counsell N; Hermsen M; Kaur RP; Zhao T; Ramanathan M; Schartinger VH; Emanuel O; Helman S; Varghese J; Dudas J; Riechelmann H; Sprung S; Haybaeck J; Howard D; Engel NW; Stewart S; Brooks L; Pickles JC; Jacques TS; Fenton TR; Williams L; Vaz FM; O'Flynn P; Stimpson P; Wang S; Hannan SA; Unadkat S; Hughes J; Dwivedi R; Forde CT; Randhawa P; Gane S; Joseph J; Andrews PJ; Royle G; Franchi A; Maragliano R; Battocchio S; Bewicke-Copley H; Pipinikas C; Webster A; Thirlwell C; Ho D; Teschendorff A; Zhu T; Steele CD; Pillay N; Vanhaesebroeck B; Mohyeldin A; Fernandez-Miranda J; Park KW; Le QT; West RB; Saade R; Manes RP; Omay SB; Vining EM; Judson BL; Yarbrough WG; Sansovini M; Silvia N; Grassi I; Bongiovanni A; Capper D; Schüller U; Thavaraj S; Sandison A; Surda P; Hopkins C; Ferrari M; Mattavelli D; Rampinelli V; Facchetti F; Nicolai P; Bossi P; Henriquez OA; Magliocca K; Solares CA; Wise SK; Llorente JL; Patel ZM; Nayak JV; Hwang PH; Lacy PD; Woods R; O'Neill JP; Jay A; Carnell D; Forster MD; Ishii M; London NR; Bell DM; Gallia GL; Castelnuovo P; Severi S; Lund VJ; Hanna EY
Eur J Cancer; 2022 Feb; 162():221-236. PubMed ID: 34980502
[TBL] [Abstract][Full Text] [Related]
10. Olfactory esthesioneuroblastoma (olfactory neuroblastoma/olfactory neuroepithelioma).
Palacios E; Valvassori G
Ear Nose Throat J; 1998 Nov; 77(11):890-1. PubMed ID: 9846465
[No Abstract] [Full Text] [Related]
11. Imaging of recurrent esthesioneuroblastoma.
Pickuth D; Heywang-Köbrunner SH
Br J Radiol; 1999 Nov; 72(863):1052-7. PubMed ID: 10700820
[TBL] [Abstract][Full Text] [Related]
12. Olfactory neuroblastoma visualized by Technetium-99m-ECD SPECT.
Prado GL; Itabashi Y; Noda H; Miura H; Mariya Y; Abe Y
Radiat Med; 2001; 19(5):267-70. PubMed ID: 11724258
[TBL] [Abstract][Full Text] [Related]
13. [Interesting case no. 9. Esthesioneuroblastoma (olfactory neuroblastoma)].
Nölle C; Stöver T; Schöffski P; Lenarz T
Laryngorhinootologie; 1998 Jan; 77(1):61-4. PubMed ID: 9522316
[No Abstract] [Full Text] [Related]
14. Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach.
Savelli G; Bartolomei M; Bignardi M
J Neurooncol; 2016 May; 127(3):617-9. PubMed ID: 26839019
[No Abstract] [Full Text] [Related]
15. Computed tomography and magnetic resonance imaging features of olfactory neuroblastoma: an analysis of 22 cases.
Pickuth D; Heywang-Köbrunner SH; Spielmann RP
Clin Otolaryngol Allied Sci; 1999 Sep; 24(5):457-61. PubMed ID: 10542931
[TBL] [Abstract][Full Text] [Related]
16. [Olfactory neuroblastoma].
Rodríguez Giambagli N; Laviano J; Kotsias S; Valentini R
Medicina (B Aires); 2016; 76(1):43. PubMed ID: 26826993
[No Abstract] [Full Text] [Related]
17. Esthesioneuroblastoma (olfactory neuroblastoma) treated with 111In-octreotide and 177Lu-DOTATATE PRRT.
Makis W; McCann K; McEwan AJ
Clin Nucl Med; 2015 Apr; 40(4):317-21. PubMed ID: 25674857
[TBL] [Abstract][Full Text] [Related]
18. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
[TBL] [Abstract][Full Text] [Related]
19. Radiology quiz case 1. Catecholamine-secreting olfactory neuroblastoma (OFN).
Nabili V; St John M; Cohan P; Lufkin R; Bhuta S; Abemayor E
Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):342, 344-5. PubMed ID: 16549757
[No Abstract] [Full Text] [Related]
20. Olfactory neuroblastoma. A report of 3 cases.
Iliades T; Printza A; Eleftheriades N; Georgios K; Psifidis A; Thomas Z
ORL J Otorhinolaryngol Relat Spec; 2002; 64(6):454-6. PubMed ID: 12499774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
